Prevention of thromboembolism in spinal cord injury -S1 guideline.


Journal

Neurological research and practice
ISSN: 2524-3489
Titre abrégé: Neurol Res Pract
Pays: England
ID NLM: 101767802

Informations de publication

Date de publication:
2020
Historique:
received: 31 08 2020
accepted: 09 09 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 17 12 2020
Statut: epublish

Résumé

Traumatic and non-traumatic spinal cord injury bears a high risk for thromboembolism in the first few months after injury. So far, there is no consented guideline regarding diagnostic and prophylactic measures to prevent thromboembolic events in spinal cord injury. Based on a Pubmed research of related original papers and review articles, international guidelines and a survey conducted in German-speaking spinal cord injury centers about best practice prophylactic procedures at each site, a consensus process was initiated, which included spinal cord medicine experts and representatives from medical societies involved in the comprehensive care of spinal cord injury patients. The recommendations comply with the German S3 practice guidelines on prevention of venous thromboembolism. Specific clinical or instrument-based screening methods are not recommended in asymptomatic SCI patients. Based on the severity of neurological dysfunction (motor completeness, ambulatory function) low dose low molecular weight heparins are recommended to be administered up to 24 weeks after injury. Besides, mechanical methods (compression stockings, intermittent pneumatic compression) can be applied. In chronic SCI patients admitted to the hospital, thromboembolism prophylactic measures need to be based on the reason for admission and the necessity for immobilization. Recommendations for thromboembolism diagnostic and prophylactic measures follow best practice in most spinal cord injury centers. More research evidence needs to be generated to administer more individually tailored risk-adapted prophylactic strategies in the future, which may help to further prevent thromboembolic events without causing major side effects. The present article is a translation of the guideline recently published online (https://www.awmf.org/uploads/tx_szleitlinien/179-015l_S1_Thromboembolieprophylaxe-bei-Querschnittlaehmung_2020-09.pdf).

Identifiants

pubmed: 33324943
doi: 10.1186/s42466-020-00089-7
pii: 89
pmc: PMC7727164
doi:

Types de publication

Journal Article

Langues

eng

Pagination

43

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors have stated that they have no conflict of interest according to the AWMF criteria.

Références

Spinal Cord. 2014 Jul;52(7):547-50
pubmed: 24819510
N Engl J Med. 1994 Dec 15;331(24):1601-6
pubmed: 7969340
World J Surg. 2010 Jan;34(1):10-9
pubmed: 20020289
PLoS One. 2018 Mar 28;13(3):e0193735
pubmed: 29590126
J Spinal Cord Med. 2020 May;43(3):353-357
pubmed: 30199352
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD005258
pubmed: 18843686
J Korean Med Sci. 2013 Sep;28(9):1382-7
pubmed: 24015047
J Spinal Cord Med. 2004;27(3):236-40
pubmed: 15478526
J Trauma. 2009 Mar;66(3):707-12
pubmed: 19276742
J Trauma. 2011 Nov;71(5):1241-5
pubmed: 22071925
Eur J Vasc Endovasc Surg. 2006 Dec;32(6):730-6
pubmed: 16931066
J Trauma Acute Care Surg. 2015 Mar;78(3):475-80; discussion 480-1
pubmed: 25710416
J Trauma. 2003 Jun;54(6):1116-24; discussion 1125-6
pubmed: 12813332
J Trauma. 2011 Oct;71(4):867-70; discussion 870-1
pubmed: 21986735
Thromb Haemost. 2013 Jan;109(1):34-8
pubmed: 23223906
Thromb Res. 2016 Nov;147:97-101
pubmed: 27721141
Hematol Oncol Clin North Am. 2000 Apr;14(2):401-16
pubmed: 10806563
Global Spine J. 2017 Sep;7(3 Suppl):138S-150S
pubmed: 29164021
Plast Reconstr Surg. 2016 Nov;138(5):908e-914e
pubmed: 27783010
Cochrane Database Syst Rev. 2014 Dec 17;(12):CD001484
pubmed: 25517473
J Thromb Haemost. 2007 Jul;5(7):1431-7
pubmed: 17419763
J Bone Joint Surg Am. 2009 Nov;91(11):2568-76
pubmed: 19884429
Int J Surg. 2017 Jul;43:94-100
pubmed: 28579397
Dtsch Med Wochenschr. 2016 Apr;141(7):453-6
pubmed: 26934866
Lancet. 2013 Aug 10;382(9891):516-24
pubmed: 23727163
Spine J. 2015 Nov 1;15(11):2338-44
pubmed: 26130085
Ann Intern Med. 2013 Aug 20;159(4):275-84
pubmed: 24026260
Ann Intern Med. 1997 Sep 15;127(6):439-45
pubmed: 9313000

Auteurs

Norbert Weidner (N)

Klinik für Paraplegiologie, Universitätsklinikum Heidelberg, Schlierbacher Landstrasse 200a, 69118 Heidelberg, Germany.

Oliver J Müller (OJ)

Klinik für Innere Medizin III, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Viola Hach-Wunderle (V)

Klinik für Gefäßchirurgie und Gefäßmedizin, Krankenhaus Nordwest, Frankfurt/M., Germany.

Karsten Schwerdtfeger (K)

Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes, Homburg Saar, Germany.

Rüdiger Krauspe (R)

Klinik und Poliklinik für Orthopädie, Universitätsklinikum, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

Rolf Pauschert (R)

Fachabteilung für Orthopädie/Unfallchirurgie, SRH Gesundheitszentrum Bad Wimpfen, Bad Wimpfen, Germany.

Christian Waydhas (C)

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum, Germany.

Michael Baumberger (M)

Paraplegikerzentrum, Nottwil, Schweiz, Nottwil, Switzerland.

Christoph Göggelmann (C)

Klinik für Paraplegiologie, Universitätsklinikum Heidelberg, Schlierbacher Landstrasse 200a, 69118 Heidelberg, Germany.
Klinik für Innere Medizin III: Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.

Gabriela Wittgruber (G)

Rehabilitationsklinik Tobelbad, Tobelbad, Austria.

Renate Wildburger (R)

Rehabilitationsklinik Tobelbad, Tobelbad, Austria.

Oswald Marcus (O)

BG Unfallklinik Frankfurt/M., Frankfurt/M., Germany.

Classifications MeSH